Catalog :




Detail Article

Folia Medica Indonesiana

ISSN 0303-7932

Vol. 43 / No. 1 / Published : 2007-01

TOC : 6, and page :28 - 31

Related with : Scholar   Yahoo!   Bing

Original Article :

Mental changes in parkinson's disease a study of fifty patients

Author :

  1. Tayseer M Zein*1
  2. Zein Mirghani*2
  1. Department of Neurology, Al-Qassimi Hospital, Sharjah
  2. College of Medicine, University of Sharjah, Sharjah United Arab Emirates

Abstract :

Neuropsychiatric disorders in Parkinson’s disease include behavioral, emotional and cognitive changes. They are common and varied and can be associated with impairments. The aim of this study is to evaluate the prevalence of the mental changes in the United Arab Emirates' patients with Parkinson’s disease and to compare these results with other studies in the literature. The importance of early detection and treatment of these mental symptoms were discussed. Fifty patients with Parkinson’s disease were assessed for the presence of depression, sleep disorders, visual hallucination, psychosis and dementia. The mean age of the patients was 71.1 years (range 55 – 92 years). The duration of the disease was 7.8 years (range 2 – 25 years). Thirteen patients (26%) had dementia, eleven patients (22%) had depression. Five patients (10%) had psychosis; four patients out of the five also had dementia. Three patients (6%) had sleep disorders and the same three patients (6%) also had visual hallucination. Visual hallucination and sleep disorders were induced by dopaminergic medications. In conclusion, psychiatric manifestations are found to be not uncommon in our patients. The results are lower than other reports in the literature. These mental changes are under-diagnosed and under-treated. Early detection and treatment of these symptoms can improve the quality of life for these patients and their care-givers.

Keyword :

Parkinson’s disease, depression, sleep disorders, visual hallucination, psychosis, dementia.,


References :

  1. J Anderson, (1980). Anti-depressive treatment in Parkinsons disease: a controlled trial of the effect of Nortriptylline treatment in Parkinsons disease treated with L-dopa. no info : Acta Neurol Scan
  2. E Aabro, (1980). Anti-depressive treatment in Parkinsons disease: a controlled trial of the effect of Nortriptylline treatment in Parkinsons disease treated with L-dopa. no info : Acta Neurol Scan
  3. N Gulmann, (1980). Anti-depressive treatment in Parkinsons disease: a controlled trial of the effect of Nortriptylline treatment in Parkinsons disease treated with L-dopa. no info : Acta Neurol Scan
  4. A Jelmsted, (1980). Anti-depressive treatment in Parkinsons disease: a controlled trial of the effect of Nortriptylline treatment in Parkinsons disease treated with L-dopa. no info : Acta Neurol Scan
  5. HE Pedersen, (1980). Anti-depressive treatment in Parkinsons disease: a controlled trial of the effect of Nortriptylline treatment in Parkinsons disease treated with L-dopa. no info : Acta Neurol Scan
  6. D Arslad, (2000). Predictors of nursing home placement in Parkinsons disease: a population based prospective study. no info : J Am Geriatr Soc
  7. M Behari, (2005). Quality of life in patients with Parkinsons disease. no info : Parkinsonisum Related Disrod
  8. AK Sirvastava, (2005). Quality of life in patients with Parkinsons disease. no info : Parkinsonisum Related Disrod
  9. RM Pandey, (2005). Quality of life in patients with Parkinsons disease. no info : Parkinsonisum Related Disrod
  10. JL Cummings, (1992). Depression and Parkinsons disease, a review. no info : Am J Psychiatry
  11. M Emre, (2004). Rivastigmine for dementia associated with Parkinsons disease. no info : N Eng J Med
  12. D Aarsland, (2004). Rivastigmine for dementia associated with Parkinsons disease. no info : N Eng J Med
  13. A Albanese, (2004). Rivastigmine for dementia associated with Parkinsons disease. no info : N Eng J Med
  14. SA Faetor, (1990). Sleep disorders and sleep effect in Parkinsons disease. no info : Mov Disord
  15. Findeyl, (2003). Direct economic impact of Parkinsons disease: a research survey in the United Kingdom. no info : Mov Disord
  16. JH Freidman, (1991). The management of the levodopa psychosis. no info : Clin Neuro Pharmacol
  17. P Gaspart, (1984). Dementia in idioplathic Parkinsons disease. A neuropathological study of 32 cases. no info : Acta Neuropathol (Ber)
  18. F Gray, (1984). Dementia in idioplathic Parkinsons disease. A neuropathological study of 32 cases. no info : Acta Neuropathol (Ber)
  19. CE Goetz, (1984). Bupropion in Parkinsons disease. no info : Neurology
  20. CM Tanner, (1984). Bupropion in Parkinsons disease. no info : Neurology
  21. HL Klawons, (1984). Bupropion in Parkinsons disease. no info : Neurology
  22. A Gulati, (2004). A clinical observation study of the pattern and occurrence of non-motor symptoms in Parkinsons disease ranging form early to advanced disease. no info : Mov Discord


   


Archive Article

Cover Media Content

Volume : 43 / No. : 1 / Pub. : 2007-01
  1. Serum p53 protein and total lymphocyte profile in sepsis patients treated with ciprofloxacin and cefotaxime
  2. Effect of loranthaceae daendropthoe species infusion on serum transaminase level and hepatic necrosis in rats
  3. Glucose 6 phosphate dehydrogenase (g6pd) deficiency in bad pregnancy history in st. vincentius a paulo catholic hospital, surabaya
  4. Heparin effect on vegf and egfr after deep second and third degree burns in rattus novergicus strain wistar
  5. Examination of oxldl serum level as the prognosis of acute thrombotic ischemic stroke
  6. Mental changes in parkinson's disease a study of fifty patients
  7. Microscopic picture and water content in dentin analysis of bonding agent bond to dentin surface an evaluation of various humidity
  8. Localization of plasmodium falciparum asexual stage antigen by mouse immune sera
  9. Description of urinary retention in women a retrospective study in dr soetomo hospital surabaya
  10. Review article: the potential intervention on apoptosis and cell cycle activity in rheumatoid arthritis
  11. Review article: the role of microglia as prime component of cns immune system in acute and chronic neuroinflammation
  12. Review article and clinical experience: a novel “two-in-one” drug fixed combination of ros and met its roles on ir, prediabetes, mets, t2dm and cvd